Osteoporosis pathogenesis and treatment: existing and emerging avenues

Osteoporotic fractures lead to increased disability and mortality in the elderly population. With the rapid increase in the aging population around the globe, more effective treatments for osteoporosis and osteoporotic fractures are urgently required. The underlying molecular mechanisms of osteoporo...

Full description

Saved in:
Bibliographic Details
Published inCellular & molecular biology letters Vol. 27; no. 1; pp. 72 - 26
Main Authors Liang, Bo, Burley, George, Lin, Shu, Shi, Yan-Chuan
Format Journal Article
LanguageEnglish
Published London BioMed Central 04.09.2022
BMC
Subjects
Bone formation
Bone remodeling
Bone resorption
MicroRNA-based therapy
Osteoporosis
Pathogenesis
Review Letter
Online AccessGet full text

Cover

More Information
Summary:Osteoporotic fractures lead to increased disability and mortality in the elderly population. With the rapid increase in the aging population around the globe, more effective treatments for osteoporosis and osteoporotic fractures are urgently required. The underlying molecular mechanisms of osteoporosis are believed to be due to the increased activity of osteoclasts, decreased activity of osteoblasts, or both, which leads to an imbalance in the bone remodeling process with accelerated bone resorption and attenuated bone formation. Currently, the available clinical treatments for osteoporosis have mostly focused on factors influencing bone remodeling; however, they have their own limitations and side effects. Recently, cytokine immunotherapy, gene therapy, and stem cell therapy have become new approaches for the treatment of various diseases. This article reviews the latest research on bone remodeling mechanisms, as well as how this underpins current and potential novel treatments for osteoporosis.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
ObjectType-Review-2
ISSN:1425-8153
1689-1392
1689-1392
DOI:10.1186/s11658-022-00371-3